HHQ16

Kundenbewertung

Based on 1 Customer Validation

HHQ16 is an orally active derivative of Astragaloside IV (HY-N0431). HHQ16 effectively reverses infarction-induced hypertrophy and heart failure by targeted degrading lnc4012/lnc9456 and antagonizing their effects on G3BP2/NF-κB signaling.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.97%
  • CAS. Nr.: 2620471-66-9
  • Formel: C30H48F2O4
  • Molecular Weight:510.70
  • Speicherung:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00